The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.

An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public trust.

The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

COVID-19 hasn’t disappeared, but it’s no longer the health threat it was. Here’s what the latest wave means and who should get boosted.

Kennedy Jr.'s effort to reshape U.S. vaccine policy, including a move to reduce the number of shots routinely recommended for ...

Anti-vaccine activists rally supporters to try to keep the momentum going on changing federal vaccine policies. This comes even as the White House tries to tamp down attention to the unpopular issue ...

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

--- ...